Skip to main content
Signal8

Senti Biosciences Holdings, Inc. (SNTI) Form SCHEDULE 13D/A — Nov 18, 2026

$SNTIForm SCHEDULE 13D/AFiled Nov 18, 2026, 5:54 PM ET0001072613-26-000911Original filing

New Enterprise Associates (NEA) filed Amendment No. 4 to its Schedule 13D on Senti Biosciences Holdings, reporting beneficial ownership of 8,775,115 shares, or 9.7% of the common stock. The filing states ownership decreased by more than 1% solely due to an increase in the number of shares outstanding, not an active sale. The 9.7% stake comprises 3,775,615 shares held of record plus a right to acquire up to 4,999,500 warrant shares, calculated against 90,705,763 outstanding shares (85,706,263 reported outstanding per Senti's Form 10-Q plus warrant shares).

Key figures

Shares Owned
8775115
Shares Outstanding
90705763
Percent Owned
9.7%
Record Shares
3775615
Warrant Shares
4999500
Outstanding Shares Per10 Q
85706263

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    Senti Biosciences Holdings, Inc. (SNTI) Form SCHEDULE 13D/A — Nov 18, 2026: AI Analysis | Signal8